As people’s awareness of global warming is growing and the struggle to preserve the environment and biodiversity is intensifying, the French Minister of Justice has adopted a circular setting out the principles and objectives to be pursued in the prevention and punishment of environmental crimes.
Companies placing hazardous mixtures on the market have to submit information about these mixtures to specific bodies appointed by European Union Member States. Poison centers use this information to give medical advice in case of an emergency.
The notification requirement, based on Annex VIII to the Classification, Labelling and Packaging (CLP) Regulation, applies from 1 January 2021.
Update on the support provided to professionals by the French Health Authority for the deployment of e-health in France
In a series of articles published this month, the Haute Autorité de Santé (French Health Authority) recalled the materials it has produced in connection with the deployment of e-health in France. The French Health Authority has indeed developed tools, guides and guidelines to support developers of apps and smart devices, practitioners wishing to set up […]
Practical recommendations of the French Health Authority for the implementation of teleconsultation and tele-expertise activities
On June 20, 2019, the Haute Autorité de la Santé (French Health Authority) published a best practice guide for the implementation and exercise of teleconsultation and tele-expertise activities. These recommendations, intended for professionals, are designed to support the operational deployment of telemedicine in France.
The year 2018 marks a significant shift in the deployment of telemedicine in France. Teleconsultations are henceforth reimbursed by the French Health Insurance Fund, just like “standard” consultations. This practice has also been liberalized through the repeal of the obligation to enter into contracts with regional health agencies and agreements between operators that carry out […]
In a judgment dated December 7, 2017, the Court of Justice of the European Union (CJEU) recalled the criteria to be applied to determine whether software constitutes a medical device. According to the findings of the CJEU, software that permits the use of data specific to a patient in particular to detect contraindications, drug interactions […]